Actively Recruiting

Age: 18Years +
All Genders
NCT06448455

Observation on the Frailty Status of Lung Cancer Patients

Led by Peking University Third Hospital · Updated on 2024-06-10

200

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Using the Integrated Conceptual Model of Frailty (ICMF) and Frailty Framework among Vulnerable Population (FFVP) as theoretical basis, the frailty status of lung cancer patients is described, and the physiological, psychological, and social frailty of lung cancer patients are comprehensively evaluated and analyzed. The influencing factors related to frailty are explored, in order to provide a basis for effective intervention research on lung cancer patients in the future.

CONDITIONS

Official Title

Observation on the Frailty Status of Lung Cancer Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Lung cancer was diagnosed by pathology or cytology
  • Age 18 years or older
  • Able to complete the questionnaire independently or with researcher guidance
  • Provide informed consent and agree to participate voluntarily
Not Eligible

You will not qualify if you...

  • Serious physical diseases such as heart, lung, kidney, or other important organ failure
  • History of dementia, mental illness, intellectual disability, or cognitive impairment
  • Blindness, deafness, or inability to speak
  • Currently participating in other studies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100083

Actively Recruiting

Loading map...

Research Team

J

Jing Wang

CONTACT

X

Xinhua Shi

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here